Oviduct response to glucagon during hysterosalpingography.
AI Summary
Key Findings
Abstract
Nine patients without evidence of tubal patency at routine hysterosalpingography were given glucagon. Five of the 9 responded with tubal dilation and spill. Three of the 4 who did not respond had a positive history and clinical examination for pelvic inflammatory disease. Data regarding side effects in the 9 patients studied are presented.
External References
- PubMed ID:
- 935416
- DOI:
- 10.1148/119.3.727
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.